Group One Trading, L.P. Revance Therapeutics, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$5.81 - $11.2 $426,029 - $821,262	73,327 Added 87.17%	157,445 $1.38 Million
Q3 2023 Nov 09, 2023	BUY	$11.47 - $25.07 $864,161 - $1.89 Million	75,341 Added 858.39%	84,118 $964,000
Q2 2023 Aug 09, 2023	SELL	$24.7 - $37.61 $469,695 - $715,191	-19,016 Reduced 68.42%	8,777 $222,000
Q1 2023 May 12, 2023	SELL	$18.36 - $35.27 $1.69 Million - $3.26 Million	-92,297 Reduced 76.86%	27,793 $895,000
Q4 2022 Feb 09, 2023	BUY	$18.32 - $30.66 $2.2 Million - $3.68 Million	120,090 New	120,090 $2.22 Million
Q2 2022 Aug 11, 2022	SELL	$11.52 - $20.4 $180,783 - $320,137	-15,693 Reduced 77.19%	4,637 $64,000
Q1 2022 May 12, 2022	BUY	$12.36 - $20.31 $251,278 - $412,902	20,330 New	20,330 $396,000
Q4 2021 Feb 11, 2022	SELL	$12.46 - $27.87 $3,937 - $8,806	-316 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$25.78 - $33.21 $199,073 - $256,447	-7,722 Reduced 96.07%	316 $9,000
Q2 2021 Aug 10, 2021	BUY	$26.8 - $31.84 $41,566 - $49,383	1,551 Added 23.91%	8,038 $238,000
Q1 2021 May 12, 2021	SELL	$24.03 - $29.97 $132,165 - $164,835	-5,500 Reduced 45.88%	6,487 $181,000
Q4 2020 Feb 10, 2021	SELL	$23.41 - $28.34 $12,500 - $15,133	-534 Reduced 4.26%	11,987 $340,000
Q3 2020 Nov 12, 2020	BUY	$23.23 - $34.3 $274,857 - $405,837	11,832 Added 1717.27%	12,521 $315,000
Q2 2020 Aug 13, 2020	BUY	$12.6 - $26.55 $7,849 - $16,540	623 Added 943.94%	689 $17,000
Q1 2020 May 13, 2020	SELL	$12.46 - $27.81 $92,316 - $206,044	-7,409 Reduced 99.12%	66 $1,000
Q4 2019 Feb 10, 2020	BUY	$11.66 - $20.15 $87,158 - $150,621	7,475 New	7,475 $121,000
Q3 2019 Nov 12, 2019	SELL	$10.22 - $14.5 $2,033 - $2,885	-199 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$15.4 - $20.39 $3,064 - $4,057	199 New	199 $3,000
Q2 2018 Aug 14, 2018	SELL	$27.45 - $33.35 $329 - $400	-12 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$29.15 - $37.4 $5,421 - $6,956	-186 Reduced 93.94%	12 $0
Q4 2017 Feb 09, 2018	SELL	$24.55 - $36.3 $19,689 - $29,112	-802 Reduced 80.2%	198 $7,000
Q3 2017 Nov 15, 2017	BUY	$22.55 - $28.1 $22,550 - $28,100	1,000	1,000 $28,000

Others Institutions Holding RVNC

# of Institutions

234

Shares Held

82.8M

Call Options Held

680K

Put Options Held

896K

Black Rock Inc. New York, NY

8.57M
Shares

$22 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.73M
Shares

$14.7 Million
0.0% of portfolio
Franklin Resources Inc San Mateo, CA

4.78M
Shares

$12.3 Million
0.0% of portfolio
Fil LTD Hamilton, D0

4.19M
Shares

$10.8 Million
0.01% of portfolio
Alpine Associates Management Inc. Englewood Cliffs, NJ

4.16M
Shares

$10.7 Million
0.49% of portfolio

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account